However, the injection of GCSF into the AML+CYT-treated group (AML+CYT+GCSF) significantly increased the RNA expression level of CREM compared to the AML+CYT-treated group without GCSF (AML+CYT) 4 weeks post-treatment (Figure 6E). Here, CSF3 is linked to acute myeloid leukemia.